Is Open Data the Silver Bullet for Better Drugs? by @gunjan_gb via @Datafloq

Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation.

A great thing to do and could give some really great results. Maybe this could be a working concept for some other industries too?

The battle over bank customer data may finally be over by Penny Crosman via @infomgmt

Guidance from the CFPB and reduced friction between banks, fintechs and data aggregators are easing bank-fintech partnerships at Wells Fargo, Capital One and others.

I can see that this has a lot of benefits, but I can also see that there are a lot of potential drawbacks as it could become a security risk. I'm also interested in how it verifies that you are the right person.